{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T18:55:48Z","timestamp":1773341748927,"version":"3.50.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det (SE)","doi-asserted-by":"publisher","award":["K2015-57X-03163-43-4"],"award-info":[{"award-number":["K2015-57X-03163-43-4"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12879-016-1750-5","type":"journal-article","created":{"date-parts":[[2016,8,11]],"date-time":"2016-08-11T12:27:07Z","timestamp":1470918427000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Reduction of Streptococcus pneumoniae in upper respiratory tract cultures and a decreased incidence of related acute otitis media following introduction of childhood pneumococcal conjugate vaccines in a Swedish county"],"prefix":"10.1186","volume":"16","author":[{"given":"Nils","family":"Littorin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonas","family":"Ahl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabian","family":"Udd\u00e9n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fredrik","family":"Resman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristian","family":"Riesbeck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,8,11]]},"reference":[{"key":"1750_CR1","unstructured":"Pneumococcal vaccines. WHO position paper \u2013 2012. Wkly Epidemiol Rec. 2012;87(14):129\u2013144."},{"key":"1750_CR2","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1098\/rstb.2011.0032","volume":"366","author":"KP Klugman","year":"2011","unstructured":"Klugman KP. Contribution of vaccines to our understanding of pneumococcal disease. Philos Trans R Soc Ld Ser B: Biol Sci. 2011;366:2790\u20138.","journal-title":"Philos Trans R Soc Ld Ser B: Biol Sci"},{"issue":"suppl 1","key":"1750_CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/1469-0691.12320","volume":"10","author":"P Durando","year":"2013","unstructured":"Durando P, Faust SN, Fletcher M, Krizova P, Torres A, Welte T. Experience with pneumococcal polysaccharide conjugate vaccine (conjugated to CRM197 carrier protein) in children and adults. Clin Microbiol Infect. 2013;10 suppl 1:1\u20139.","journal-title":"Clin Microbiol Infect"},{"key":"1750_CR4","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1097\/INF.0b013e31824de9f6","volume":"5","author":"S Fitzwater","year":"2012","unstructured":"Fitzwater S, Chandran A, Santosham M, Johnson HL. The worldwide impact of the seven-valent pneumococcal conjugate vaccine. Pediatr Infect Dis J. 2012;5:501\u20138.","journal-title":"Pediatr Infect Dis J"},{"key":"1750_CR5","first-page":"CD004977","volume":"4","author":"MG Lucero","year":"2009","unstructured":"Lucero MG, Dulalia VE, Nillos LT, Williams G, Parre\u00f1o RA, Nohynek H, et al. Pneumococcal conjugate vaccines for preventing vaccine-type invasive pneumococcal disease and X-ray defined pneumonia in children less than two years of age. Cochrane Database Syst Rev. 2009;4:CD004977.","journal-title":"Cochrane Database Syst Rev"},{"key":"1750_CR6","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1542\/peds.2013-4177","volume":"12","author":"A Lindstrand","year":"2014","unstructured":"Lindstrand A, Bennet R, Galanis I, Blennow M, Ask LS, Dennison SH, et al. Sinusitis and pneumonia hospitalization after introduction of pneumococcal conjugate vaccine. Pediatrics. 2014;12:1528\u201336.","journal-title":"Pediatrics"},{"key":"1750_CR7","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1056\/NEJMoa1408544","volume":"3","author":"MJ Bonten","year":"2015","unstructured":"Bonten MJ, Huijts SM, Bolkenbaas M, Webber C, Patterson S, Gault S, et al. Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults. N Engl J Med. 2015;3:1114\u201325.","journal-title":"N Engl J Med"},{"key":"1750_CR8","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1016\/S0140-6736(10)62225-8","volume":"12","author":"M Weinberger","year":"2011","unstructured":"Weinberger M, Malley R, Lipsitch M. Serotype replacement in disease following pneumococcal vaccination: a discussion of the evidence. Lancet. 2011;12:1962\u201373.","journal-title":"Lancet"},{"key":"1750_CR9","doi-asserted-by":"crossref","first-page":"e88406","DOI":"10.1371\/journal.pone.0088406","volume":"9","author":"G Regev-Yochay","year":"2014","unstructured":"Regev-Yochay G, Galia Rahav G, Klaris Riesenberg K, Wiener-Well Y, Strahilevitz J, Stein M, et al. Initial effects of the national PCV7 childhood immunization program on adult invasive pneumococcal disease in Israel. PLoS One. 2014;9:e88406.","journal-title":"PLoS One"},{"key":"1750_CR10","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/INF.0b013e3181c15471","volume":"4","author":"KK Hsu","year":"2010","unstructured":"Hsu KK, Shea KM, Stevenson AE, Pelton SI. Changing serotypes causing childhood invasive pneumococcal disease: Massachusetts, 2001\u20132007. Pediatr Infect Dis J. 2010;4:289\u201393.","journal-title":"Pediatr Infect Dis J"},{"key":"1750_CR11","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1086\/341896","volume":"5","author":"DR Feikin","year":"2002","unstructured":"Feikin DR, Klugman KP. Historical changes in pneumococcal serogroup distribution: implications for the era of pneumococcal conjugate vaccines. Clin Infect Dis. 2002;5:547\u201355.","journal-title":"Clin Infect Dis"},{"key":"1750_CR12","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1097\/INF.0b013e31803df9ca","volume":"6","author":"SI Pelton","year":"2007","unstructured":"Pelton SI, Huot H, Finkelstein JA, Bishop CJ, Hsu KK, Kellenberg J, et al. Emergence of 19A as virulent and multidrug resistant pneumococcus in Massachusetts following universal immunization of infants with pneumococcal conjugate vaccine. Pediatr Infect Dis J. 2007;6:468\u201372.","journal-title":"Pediatr Infect Dis J"},{"key":"1750_CR13","doi-asserted-by":"crossref","unstructured":"Fortanier AC, Jansen AG, Hak E, Hak E, Schilder AG, Sanders EA, et al. Pneumococcal conjugate vaccines for preventing otitis media. Cochrane Database Syst Rev. 2014;4:CD001480.","DOI":"10.1002\/14651858.CD001480.pub4"},{"key":"1750_CR14","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/S0140-6736(06)68304-9","volume":"3","author":"R Prymula","year":"2006","unstructured":"Prymula R, Peeters P, Chrobok V, Kriz P, Novakova E, Kaliskova E, et al. Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typable Haemophilus influenzae: a randomised double-blind efficacy study. Lancet. 2006;3:740\u20138.","journal-title":"Lancet"},{"key":"1750_CR15","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1586\/14760584.7.1.83","volume":"2","author":"CG Grijalva","year":"2008","unstructured":"Grijalva CG, Griffin MR. Population-based impact of routine infant immunization with pneumococcal conjugate vaccine in the USA. Expert Rev Vaccines. 2008;2:83\u201395.","journal-title":"Expert Rev Vaccines"},{"key":"1750_CR16","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/1471-2431-14-200","volume":"14","author":"AJ Leach","year":"2014","unstructured":"Leach AJ, WiggerC A, Chatfield M, Smith-Vaughan H, Morris PS. Otitis media in children vaccinated during consecutive 7-valent or 10-valent pneumococcal conjugate vaccination schedules. BMC Pediatrics. 2014;14:200.","journal-title":"BMC Pediatrics"},{"key":"1750_CR17","doi-asserted-by":"crossref","first-page":"457","DOI":"10.2217\/fmb.12.23","volume":"4","author":"N Principi","year":"2012","unstructured":"Principi N, Baggi E, Esposito S. Prevention of acute otitis media using currently available vaccines. Future Microbiol. 2012;4:457\u201365.","journal-title":"Future Microbiol"},{"key":"1750_CR18","unstructured":"Child healthcare services Sk\u00e5ne county, Swedish institute for prevention of contagious diseases (SMI). Statistics on vaccination, annual report. 2012."},{"key":"1750_CR19","unstructured":"Sk\u00e5ne county health services. Regional guidelines for upper respiratory culture. 2015. Available from: http:\/\/www.skane.se\/Upload\/Webbplatser\/Labmedicin\/Verksamhetsomr%C3%A5den\/Klinisk%20mikrobiologi\/Analysportal\/L%C3%A4s%20mer\/%C3%96vre_luftv%C3%A4gar.pdf ."},{"key":"1750_CR20","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1186\/1471-2334-13-492","volume":"10","author":"J Ahl","year":"2013","unstructured":"Ahl J, Littorin N, Forsgren A, Odenholt I, Resman F, Riesbeck K. High incidence of septic shock caused by Streptococcus pneumoniae serotype 3 - a retrospective epidemiological study. BMC Infect Dis. 2013;10:492.","journal-title":"BMC Infect Dis"},{"key":"1750_CR21","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1128\/JCM.42.6.2518-2522.2004","volume":"6","author":"H-C Slotved","year":"2004","unstructured":"Slotved H-C, Kaltoft M, Skovsted IC, Kerrn MB, Espersen F. Simple, rapid latex agglutination test for serotyping of pneumococci (Pneumotest-Latex). J Clin Microbiol. 2004;6:2518\u201322.","journal-title":"J Clin Microbiol"},{"key":"1750_CR22","first-page":"699","volume":"6","author":"R Austrian","year":"1976","unstructured":"Austrian R. The Quellung reaction, a neglected microbiologic technique. Mt Sinai J Med. 1976;6:699\u2013709.","journal-title":"Mt Sinai J Med"},{"key":"1750_CR23","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/INF.0000000000000536","volume":"2","author":"SO Tamir","year":"2015","unstructured":"Tamir SO, Roth Y, Dalal I, Goldfarb A, Grotto I, Marom T. Changing trends of acute otitis media bacteriology in central Israel in the pneumococcal conjugate vaccines era. Pediatr Infect Dis J. 2015;2:195\u20139.","journal-title":"Pediatr Infect Dis J"},{"key":"1750_CR24","unstructured":"Public health agency web publications. Historical records on influenza surveillance reports. 2013. Available from: https:\/\/www.folkhalsomyndigheten.se\/nyheter-och-press\/historik-smi-2003-2013\/historik-smi-nyheter\/2013\/maj\/lang-och-svar-influensasasong\/ ."},{"key":"1750_CR25","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3109\/00365548.2014.1001997","volume":"6","author":"JG Ahn","year":"2015","unstructured":"Ahn JG, Choi SY, Kim DS, Kim KH. Changes in pneumococcal nasopharyngeal colonization among children with respiratory tract infections before and after use of the two new extended-valency pneumococcal conjugated vaccines. Infect Dis (Lond). 2015;6:385\u201392.","journal-title":"Infect Dis (Lond)"},{"key":"1750_CR26","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1471-2431-10-4","volume":"10","author":"WP Hausdorff","year":"2010","unstructured":"Hausdorff WP, Hoet B, Schuerman L. Do pneumococcal conjugate vaccines provide any cross-protection against serotype 19A? BMC Pediatr. 2010;10:4.","journal-title":"BMC Pediatr"},{"key":"1750_CR27","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1586\/erv.11.8","volume":"3","author":"J Poolman","year":"2011","unstructured":"Poolman J, Borrow R. Hyporesponsiveness and its clinical implications after vaccination with polysaccharide or glycoconjugate vaccines. Expert Rev Vaccines. 2011;3:307\u201322.","journal-title":"Expert Rev Vaccines"},{"key":"1750_CR28","first-page":"145","volume":"2","author":"PL Ho","year":"2015","unstructured":"Ho PL, Chiu SS, Law PY, Chan EL, Lai EL, Chow KH. Increase in the nasopharyngeal carriage of non-vaccine serogroup 15 Streptococcus pneumoniae after introduction of children pneumococcal conjugate vaccination in Hong Kong. Diagn Microbiol Infect Dis. 2015;2:145\u20138.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"1750_CR29","doi-asserted-by":"crossref","first-page":"4033","DOI":"10.1016\/j.vaccine.2013.04.074","volume":"8","author":"EL Parra","year":"2013","unstructured":"Parra EL, De La Hoz F, D\u00edaz PL, Sanabria O, Realpe ME, Moreno J. Changes in Streptococcus pneumoniae serotype distribution in invasive disease and nasopharyngeal carriage after the heptavalent pneumococcal conjugate vaccine introduction in Bogot\u00e1, Colombia. Vaccine. 2013;8:4033\u20138.","journal-title":"Vaccine"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-016-1750-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,5]],"date-time":"2022-07-05T20:19:40Z","timestamp":1657052380000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-016-1750-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,11]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["1750"],"URL":"https:\/\/doi.org\/10.1186\/s12879-016-1750-5","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,11]]},"article-number":"407"}}